SMT201700512T1 - Formulazioni farmaceutiche comprendenti metallo-porfirine contenenti carborano - Google Patents

Formulazioni farmaceutiche comprendenti metallo-porfirine contenenti carborano

Info

Publication number
SMT201700512T1
SMT201700512T1 SM20170512T SMT201700512T SMT201700512T1 SM T201700512 T1 SMT201700512 T1 SM T201700512T1 SM 20170512 T SM20170512 T SM 20170512T SM T201700512 T SMT201700512 T SM T201700512T SM T201700512 T1 SMT201700512 T1 SM T201700512T1
Authority
SM
San Marino
Prior art keywords
carborane
porphyrins
pharmaceutical formulations
containing metallo
metallo
Prior art date
Application number
SM20170512T
Other languages
English (en)
Inventor
Chris Beattie
James Rennie
Anne Wadsworth
Original Assignee
Morex Dev Partners Llp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morex Dev Partners Llp filed Critical Morex Dev Partners Llp
Publication of SMT201700512T1 publication Critical patent/SMT201700512T1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SM20170512T 2012-11-23 2013-11-22 Formulazioni farmaceutiche comprendenti metallo-porfirine contenenti carborano SMT201700512T1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1221125.6A GB201221125D0 (en) 2012-11-23 2012-11-23 Pharmaceutial formulations
EP13801495.6A EP2922571B1 (en) 2012-11-23 2013-11-22 Pharmaceutical formulations comprising carborane-containing metallo-porphyrins
PCT/EP2013/074490 WO2014079977A1 (en) 2012-11-23 2013-11-22 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
SMT201700512T1 true SMT201700512T1 (it) 2018-01-11

Family

ID=47560584

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20170512T SMT201700512T1 (it) 2012-11-23 2013-11-22 Formulazioni farmaceutiche comprendenti metallo-porfirine contenenti carborano

Country Status (20)

Country Link
US (1) US9358290B2 (it)
EP (1) EP2922571B1 (it)
JP (1) JP6279599B2 (it)
KR (1) KR20150086283A (it)
CN (1) CN104853777B (it)
CA (1) CA2890271A1 (it)
CY (1) CY1119713T1 (it)
DK (1) DK2922571T3 (it)
ES (1) ES2646010T3 (it)
GB (1) GB201221125D0 (it)
HR (1) HRP20171652T1 (it)
HU (1) HUE035198T2 (it)
LT (1) LT2922571T (it)
NO (1) NO2922571T3 (it)
PL (1) PL2922571T3 (it)
PT (1) PT2922571T (it)
RS (1) RS56499B1 (it)
SI (1) SI2922571T1 (it)
SM (1) SMT201700512T1 (it)
WO (1) WO2014079977A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201212409D0 (en) * 2012-07-12 2012-08-22 Morex Dev Partners Llp Cancer treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925736A (en) 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
JP2005513001A (ja) 2001-11-09 2005-05-12 キュー エル ティー インク． 脱毛治療のための光力学療法
US6995260B2 (en) * 2004-05-20 2006-02-07 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8287839B2 (en) * 2006-12-04 2012-10-16 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8444953B2 (en) * 2007-03-22 2013-05-21 Brookhaven Science Associates, Llc Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
EP2194027A4 (en) * 2007-09-03 2011-04-27 Kawamura Inst Chem Res METHOD FOR PRODUCING A STRUCTURE COATED WITH A NANOSTRUCTURE COMPOSITE, A STRUCTURE COATED WITH A NANOSTRUCTURE COMPOUND AND A NANOSTRUCTURED COMPOSITE STRUCTURE REACTOR
GB0819594D0 (en) 2008-10-24 2008-12-03 Univ Coimbrra Process
GB201212409D0 (en) * 2012-07-12 2012-08-22 Morex Dev Partners Llp Cancer treatment

Also Published As

Publication number Publication date
NO2922571T3 (it) 2018-02-03
SI2922571T1 (sl) 2017-12-29
CA2890271A1 (en) 2014-05-30
EP2922571A1 (en) 2015-09-30
HRP20171652T1 (hr) 2017-12-15
PT2922571T (pt) 2017-11-07
RS56499B1 (sr) 2018-01-31
LT2922571T (lt) 2017-11-10
GB201221125D0 (en) 2013-01-09
KR20150086283A (ko) 2015-07-27
EP2922571B1 (en) 2017-09-06
CN104853777B (zh) 2019-03-08
WO2014079977A1 (en) 2014-05-30
JP2016500090A (ja) 2016-01-07
ES2646010T3 (es) 2017-12-11
PL2922571T3 (pl) 2018-03-30
US9358290B2 (en) 2016-06-07
CN104853777A (zh) 2015-08-19
CY1119713T1 (el) 2018-06-27
JP6279599B2 (ja) 2018-02-14
US20150297717A1 (en) 2015-10-22
DK2922571T3 (da) 2017-11-13
HK1209339A1 (en) 2016-04-01
HUE035198T2 (hu) 2018-05-02

Similar Documents

Publication Publication Date Title
PT3725778T (pt) Formulações de enzalutamida
ZA201407373B (en) Novel pharmaceutical formulations
ZA201503594B (en) Pharmaceutical compositions
ZA201501930B (en) Pharmaceutical composition
IL232305A0 (en) pharmaceutical preparations
EP2832730A4 (en) MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION
ZA201409020B (en) Pharmaceutical formulation
AP2015008208A0 (en) Pharmaceutical administration forms comprising
ZA201405925B (en) Pharmaceutical formulation having improved stability
SG11201509194SA (en) Radiomitigating pharmaceutical formulations
HUE037618T2 (hu) Gyógyszerészeti kombinációk
ZA201502987B (en) Pharmaceutical composition
IL235988B (en) Drug composition is based on genotype or phenotype
PL2908859T3 (pl) Formulacje arypiprazolu
GB201211153D0 (en) Pharmaceutical compositions
SI2922571T1 (sl) Farmacevtske formulacije obsegajoče karboran vsebujoče kovinske porfirine
BR112014021433A2 (pt) formulações farmacêuticas
GB201211403D0 (en) Pharmaceutical formulations
GB201211406D0 (en) Pharmaceutical formulations
IL238075A0 (en) pharmaceutical preparations
ECSP12011630A (es) Formulación farmacéutica
GB201206178D0 (en) Formulations
GB201219234D0 (en) Pharmaceutical compositions
GB201213303D0 (en) Pharmaceutical compositions
GB201204810D0 (en) Pharmaceutical compositions